A quantitative analysis of N-myc downstream regulated gene 2 (NDRG 2) in human tissues and cell lysates by

Mi-Young Park1, Seung-Chul Choi, Hayang Sin Lee

  • 1Stem Cell Research Center, KRIBB, Daejeon 305-806, South Korea.

Abstract

Insights

A new protein microarray assay accurately measures N-myc downstream regulated gene 2 (NDRG2) levels. NDRG2 was significantly lower in liver cancer tissues, supporting its role as a tumor suppressor.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Oncology

Background:

  • N-myc downstream regulated gene 2 (NDRG2) is a potential tumor suppressor.
  • The NDRG family includes NDRG1-4.
  • NDRG2 levels in human tissues require accurate assessment.

Purpose of the Study:

  • To develop a reverse-phase protein microarray assay for quantifying NDRG2.
  • To evaluate NDRG2 expression in human tissue specimens and cell lines.

Main Methods:

  • Synthesized recombinant NDRG2 protein and developed specific monoclonal antibodies (mAbs).
  • Utilized a protein microarray technique involving mAb incubation, biotin-linked secondary antibodies, and HRP-conjugated streptavidin.
  • Measured color development using GenePix software to determine NDRG2 concentrations.

Main Results:

  • The assay demonstrated linearity (0-10 ng/ml) and high sensitivity (50 pg/ml).
  • NDRG2 concentrations were significantly reduced in hepatocellular carcinoma liver tissues compared to normal liver tissues.
  • Assay results correlated well with Western blot analysis.

Conclusions:

  • The developed protein microarray is a sensitive and accurate tool for assessing NDRG2.
  • This method is applicable for protein analysis in human tissues and cell lines.
  • The findings support NDRG2's role in cancer and pathological research.